FTC sues 3 top pharmacy managers over price inflation
By Jack Aylmer (Anchor/Reporter), Mathew Grisham (Digital Producer), Mirlie Larose (Producer), Jack Henry (Video Editor)
In a major move against the pharmaceutical industry, the U.S. Federal Trade Commission is taking legal action against three of the country’s largest pharmacy benefit managers, or PBMs. The companies are CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx.
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this dataBias Distribution
Left
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on Associated Press NewsHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on abc NewsFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on CNNFTC Sues Drug Middlemen Over Manipulating Insulin Market
Click to see story on BloombergFederal Trade Commission accuses three drug middlemen of inflating insulin prices
Click to see story on NBC NewsFeds sue pharmacy gatekeepers over high insulin costs
Click to see story on PoliticoUS FTC Sues Drug ‘Gatekeepers’ Over High Insulin Prices
Click to see story on U.S. NewsUS FTC sues drug ‘gatekeepers’ over high insulin prices
Click to see story on ReutersFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KIFIFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KRDOFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on CNBCFTC sues three largest drug middlemen for allegedly inflating insulin prices
Click to see story on The HillUS Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth’s Pharmacy Benefit Managers For Inflating Insulin Prices – CVS Health (NYSE:CVS), Cigna (NYSE:CI), UnitedHealth Group (NYSE:UNH)
Click to see story on BenzingaFTC sues prescription drug middlemen, alleging they conspired over high insulin costs
Click to see story on UPIHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on Washington Top NewsFTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Click to see story on MarketWatchU.S. sues drug middlemen, alleging improper insulin price increases
Click to see story on Spectrum Local NewsFTC Accuses Drug Middlemen of Inflating Insulin Prices
Click to see story on Wall Street JournalHigh insulin prices spur federal lawsuit against 3 pharmacy benefit managers
Click to see story on WPRI 12High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WFAA 8abcUS drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Click to see story on Financial TimesHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WKYCFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KEYTFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices – KION546
Click to see story on KIONFTC Sues Top Pharmacy Benefit Managers Over Insulin Prices
Click to see story on MedPage TodayBREAKING: FTC Accuses Drug Middlemen Of Raising Insulin Prices
Click to see story on Law360FTC sues major pharmacy benefit managers over insulin prices
Click to see story on healthcaredive.comRight
Untracked Bias
High insulin prices spur a federal lawsuit against three pharmacy benefit managers – The Morning Sun
Click to see story on Morning SunHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WBALFTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Click to see story on BizTocFTC Sues Major Pharmacy Benefit Managers Over Alleged Insulin Price Inflation
Click to see story on The World Without Fake News!Drug middlemen illegally drive up the cost of insulin, FTC says
Click to see story on BalkansTimesDrug middlemen illegally drive up the cost of insulin, FTC says
Click to see story on News Talk 94.1/AM 1600FTC recordsdata a declare towards drugs intermediaries for purportedly blowing up insulin prices
Click to see story on India Daily MailFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on Stockxpo – A professional network of traders, investors and analystsHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on The Business JournalFTC Sues Pharmacy Middlemen for Allegedly Driving Up Insulin Prices
Click to see story on The News GodFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on JingletreeHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on thealbertan.comFTC to sue major PBMs over insulin rebates, claiming they inflated patient cost
Click to see story on Endpoints NewsFTC sues prescription-drug middlemen over insulin costs, says drugmakers are additionally ‘on discover’
Click to see story on news247planet.comFTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
Click to see story on ajmc.comPBM insulin practices violated Section 5, FTC says
Click to see story on globalcompetitionreview.comFTC sues drug middlemen over insulin prices, puts others on notice
Click to see story on cardiovascularbusiness.comThe FTC filed a lawsuit on Friday, Sept. 20, accusing the companies of steering diabetes patients toward higher-priced insulin to secure millions in rebates from pharmaceutical companies. The FTC alleges that companies — and their affiliated group purchasing organizations — built a system that prioritizes high rebates from drug manufacturers.
Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.
Point phone camera here
The legal action is part of a broader effort by the Biden administration to tackle rising drug prices. Meanwhile, companies are pushing back. CVS said the FTC’s allegations are “simply wrong” and insists it has worked to lower insulin costs.
Cigna’s Chief Legal Officer Andrea Nelson called the lawsuit politically motivated, arguing that if the FTC succeeds in forcing PBMs to include more expensive drugs in the coverage plans, it could actually lead to higher drug prices across the board.
The FTC said the goal is to fix a broken system that drives up drug prices.
Jack Aylmer
IN A MAJOR MOVE AGAINST THE PHARMACEUTICAL INDUSTRY, THE U.S. FEDERAL TRADE COMMISSION IS TAKING LEGAL ACTION AGAINST THREE OF THE COUNTRY’S LARGEST PHARMACY BENEFIT MANAGERS or PBMs.
THE COMPANIES ARE C-V-S HEALTH’S CARE-MARK R-X, CIGNA’S EXPRESS SCRIPTS, AND UNITEDHEALTH GROUP’S OPTUM-R-X
THE FTC FILED A LAWSUIT ON FRIDAY, ACCUSING THEM OF STEERING DIABETES PATIENTS TOWARD HIGHER-PRICED INSULIN TO SECURE MILLIONS IN REBATES FROM PHARMACEUTICAL COMPANIES.
THE F-T-C ALLEGES THE COMPANIES – AND THEIR AFFILIATED GROUP PURCHASING ORGANIZATIONS – BUILT A SYSTEM THAT PRIORITIZES HIGH REBATES FROM DRUG MANUFACTURERS.
THIS LEGAL ACTION IS PART OF A BROADER EFFORT BY THE BIDEN ADMINISTRATION TO TACKLE RISING DRUG PRICES.
MEANWHILE, THE COMPANIES ARE PUSHING BACK. CVS SAYS THE FTC’S ALLEGATIONS ARE ‘SIMPLY WRONG’ AND INSISTS IT’S WORKED TO LOWER INSULIN COSTS.
CIGNA’S CHIEF LEGAL OFFICER, CALLED THE LAWSUIT POLITICALLY MOTIVATED, ARGUING THAT IF THE FTC SUCCEEDS IN FORCING PBMs TO INCLUDE MORE EXPENSIVE DRUGS IN COVERAGE PLANS, IT COULD ACTUALLY LEAD TO HIGHER DRUG PRICES ACROSS THE BOARD.
THE FTC SAYS THE GOAL IS TO FIX A BROKEN SYSTEM THAT DRIVES UP DRUG PRICES ACROSS THE BOARD.
AS THIS CASE UNFOLDS, WE’LL BE FOLLOWING THE DEVELOPMENT TO SEE HOW THIS FIGHT OVER DRUG PRICING IMPACTS PATIENTS, THE HEALTHCARE INDUSTRY, AND THE BROADER PUSH TO BRING RELIEF TO THOSE STRUGGLING WITH HIGH PRESCRIPTION COSTS.
FOR SAN, I’M JACK AYLMER
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this dataBias Distribution
Left
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on Associated Press NewsHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on abc NewsFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on CNNFTC Sues Drug Middlemen Over Manipulating Insulin Market
Click to see story on BloombergFederal Trade Commission accuses three drug middlemen of inflating insulin prices
Click to see story on NBC NewsFeds sue pharmacy gatekeepers over high insulin costs
Click to see story on PoliticoUS FTC Sues Drug ‘Gatekeepers’ Over High Insulin Prices
Click to see story on U.S. NewsUS FTC sues drug ‘gatekeepers’ over high insulin prices
Click to see story on ReutersFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KIFIFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KRDOFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on CNBCFTC sues three largest drug middlemen for allegedly inflating insulin prices
Click to see story on The HillUS Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth’s Pharmacy Benefit Managers For Inflating Insulin Prices – CVS Health (NYSE:CVS), Cigna (NYSE:CI), UnitedHealth Group (NYSE:UNH)
Click to see story on BenzingaFTC sues prescription drug middlemen, alleging they conspired over high insulin costs
Click to see story on UPIHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on Washington Top NewsFTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Click to see story on MarketWatchU.S. sues drug middlemen, alleging improper insulin price increases
Click to see story on Spectrum Local NewsFTC Accuses Drug Middlemen of Inflating Insulin Prices
Click to see story on Wall Street JournalHigh insulin prices spur federal lawsuit against 3 pharmacy benefit managers
Click to see story on WPRI 12High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WFAA 8abcUS drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Click to see story on Financial TimesHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WKYCFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Click to see story on KEYTFederal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices – KION546
Click to see story on KIONFTC Sues Top Pharmacy Benefit Managers Over Insulin Prices
Click to see story on MedPage TodayBREAKING: FTC Accuses Drug Middlemen Of Raising Insulin Prices
Click to see story on Law360FTC sues major pharmacy benefit managers over insulin prices
Click to see story on healthcaredive.comRight
Untracked Bias
High insulin prices spur a federal lawsuit against three pharmacy benefit managers – The Morning Sun
Click to see story on Morning SunHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on WBALFTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Click to see story on BizTocFTC Sues Major Pharmacy Benefit Managers Over Alleged Insulin Price Inflation
Click to see story on The World Without Fake News!Drug middlemen illegally drive up the cost of insulin, FTC says
Click to see story on BalkansTimesDrug middlemen illegally drive up the cost of insulin, FTC says
Click to see story on News Talk 94.1/AM 1600FTC recordsdata a declare towards drugs intermediaries for purportedly blowing up insulin prices
Click to see story on India Daily MailFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on Stockxpo – A professional network of traders, investors and analystsHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on The Business JournalFTC Sues Pharmacy Middlemen for Allegedly Driving Up Insulin Prices
Click to see story on The News GodFTC sues drug middlemen for allegedly inflating insulin prices
Click to see story on JingletreeHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
Click to see story on thealbertan.comFTC to sue major PBMs over insulin rebates, claiming they inflated patient cost
Click to see story on Endpoints NewsFTC sues prescription-drug middlemen over insulin costs, says drugmakers are additionally ‘on discover’
Click to see story on news247planet.comFTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
Click to see story on ajmc.comPBM insulin practices violated Section 5, FTC says
Click to see story on globalcompetitionreview.comFTC sues drug middlemen over insulin prices, puts others on notice
Click to see story on cardiovascularbusiness.comVOTE WITH THE UNBIASED, STRAIGHT FACTS.™
We promise you context and clarity when it matters the most!
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
MOST POPULAR
-
Earthquake in Iran fuels online speculation of nuclear testing
Read4 hrs ago -
What the ‘Waffle House Index’ is telling us about Hurricane Milton
Watch 2:369 hrs ago -
Secret Pentagon UFO program allegedly operating without Congress’ knowledge
Watch 1:5810 hrs ago -
Sexual assault allegations revealed within the CIA: Report
Watch 2:1010 hrs ago